Kenneth E. Ugen
8Patents
4h-index
7Co-inventors
50Inventor score
Filing activity: Mar 24, 1994 → Dec 3, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5556744A | Methods and compositions for diagnosing and treating certain HIV infected patients | Emerging Cross-Sectional Technologies | 44 | Expired |
| US8927518B1 | Method for the treatment of malignancies | Human Necessities | 12 | Active |
| US6348449B1 | Methods of inducing mucosal immunity | Chemistry; Metallurgy | 11 | Expired |
| US10143759B1 | Method for the treatment of malignancies | Human Necessities | 5 | Active |
| US7220728B2 | Methods of inducing mucosal immunity | Chemistry; Metallurgy | 2 | Expired |
| US10792375B2 | Method for the treatment of malignancies | Human Necessities | 0 | Active |
| US8067430B1 | Anti-HIV activity of the opioid antagonist naloxone | Human Necessities | 0 | Active |
| US8536145B2 | Methods of inducing mucosal immunity | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.